Increased Systemic Immune-Inflammation Index Was Associated with Type 2 Diabetic Peripheral Neuropathy: A Cross-Sectional Study in the Chinese Population
Jia Li,Xing Zhang,Yi Zhang,Xiaofang Dan,Xian Wu,Yuxia Yang,Xiping Chen,Shengxi Li,Yong Xu,Qin Wan,Pijun Yan
DOI: https://doi.org/10.2147/jir.s433843
IF: 4.5
2023-12-11
Journal of Inflammation Research
Abstract:Jia Li, 1– 5, &ast Xing Zhang, 1– 5, &ast Yi Zhang, 1– 5, &ast Xiaofang Dan, 1– 5 Xian Wu, 1– 5 Yuxia Yang, 1– 5 Xiping Chen, 6 Shengxi Li, 7 Yong Xu, 1– 5 Qin Wan, 1– 5 Pijun Yan 1– 5 1 Department of Endocrinology and Metabolism, the Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China; 2 Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, People's Republic of China; 3 Sichuan Clinical Research Center for Nephropathy, Luzhou, People's Republic of China; 4 Cardiovascular and Metabolic Diseases Key Laboratory of Luzhou, Luzhou, People's Republic of China; 5 Sichuan Clinical Research Center for Diabetes and Metabolism, Luzhou, China, Luzhou, People's Republic of China; 6 Clinical medical college, Southwest Medical University, Luzhou, People's Republic of China; 7 Basic Medical College, Southwest Medical University, Luzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Pijun Yan, Department of Endocrinology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China, Tel/Fax +86-830-3165361, Email Background: Systemic immune-inflammation index (SII), a novel inflammatory marker, has been demonstrated to be associated with type 2 diabetes mellitus (T2DM) and its vascular complications, however, the relation between SII and diabetic peripheral neuropathy (DPN) has been never reported. We aimed to explore whether SII is associated with DPN in Chinese population. Methods: A cross-sectional study was conducted among 1460 hospitalized patients with T2DM. SII was calculated as the platelet count × neutrophil count/lymphocyte count, and its possible association with DPN was investigated by correlation and multivariate logistic regression analysis, and subgroup analyses. Results: Patients with higher SII quartiles had higher vibration perception threshold and prevalence of DPN (all P < 0.01), and SII was independently positively associated with the prevalence of DPN ( P < 0.01). Multivariate logistic regression analysis showed that the risk of prevalence of DPN increased progressively across SII quartiles ( P for trend < 0.01), and participants in the highest quartile of SII was at a significantly increased risk of prevalent DPN compared to those in the lowest quartile after adjustment for potential confounding factors (odds rate: 1.211, 95% confidence intervals 1.045– 1.404, P < 0.05). Stratified analysis revealed positive associations of SII quartiles with risk of prevalent DPN only in men, people less than 65 years old, with body mass index < 24 kg/m 2 , duration of diabetes > 5 years, hypertension, dyslipidaemia, poor glycaemic control, and estimated glomerular filtration rate < 90 mL/min/1.73 m 2 ( P for trend < 0.01 or P for trend < 0.05). The receiver operating characteristic curve analysis revealed that the optimal cut-off point of SII for predicting DPN was 617.67 in patients with T2DM, with a sensitivity of 45.3% and a specificity of 73%. Conclusion: The present study showed that higher SII is independently associated with increased risk of DPN, and SII might serve as a new risk biomarker for DPN in Chinese population. Keywords: systemic immune-inflammation index, diabetic peripheral neuropathy, vibration perception threshold, type 2 diabetes mellitus, Chinese population Diabetic peripheral neuropathy (DPN) is one of the most common long-term complications of diabetes that frequently presents with peripheral nerve dysfunction accompanied with typical characteristics of pain and numbness, which not only results in an increase in the risk of foot ulceration and subsequent amputation, but also leads to a considerable disability and cardiovascular mortality. 1–3 Therefore, DPN has posted a great challenge for both medical professionals and the entire society. Despite a high lifetime prevalence of approximately 50%, 4 the symptoms are insidious in onset, 1 and there is no approved therapy to prevent or cure DPN apart from good glycemic therapy. 3 Therefore, emphasis should be laid on effective surveillance, early detection and diagnosis of DPN. Although the pathogenesis is complex and not well established, chronic inflammation has been suggested to be involved in the occurrence and development of DPN. 5,6 Recently, close interaction of inflammation and immune system-related cells such as neutrophils, lympho -Abstract Truncated-
immunology